1. BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma. Issue 1 (December 2016) Authors: Yin, Guozhi; Liu, Zhikui; Wang, Yufeng; Dou, Changwei; Li, Chao; Yang, Wei; Yao, Yingmin; Liu, Qingguang; Tu, Kangsheng Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Corrigendum to "PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1" [Cancer Letters 375 (1) (2016 May 28) 190–198]. (1st September 2022) Authors: Li, Qing; Liu, Zhikui; Xu, Meng; Xue, Yumo; Yao, Bowen; Dou, Changwei; Jia, Yuli; Wang, Yufeng; Tu, Kangsheng; Zheng, Xin; Yao, Yingmin Journal: Cancer letters Issue: Volume 543(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Is the regulatory effect of PCAF and sirtuin 7 on phosphoglycerate kinase 1 acetylation a universal mechanism underlying hepatocellular carcinoma progression?. Issue 5 (11th October 2017) Authors: Dou, Changwei; Zheng, Xin; Liu, Qingguang; Tu, Kangsheng Journal: Hepatology Issue: Volume 66:Issue 5(2017) Page Start: 1699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Lymphocyte‐specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation. Issue 12 (7th November 2016) Authors: Zhang, Hongyong; Wang, Yufeng; Liu, Zhikui; Yao, Bowen; Dou, Changwei; Xu, Meng; Li, Qing; Jia, Yuli; Wu, Shengli; Tu, Kangsheng; Liu, Qingguang Journal: FEBS open bio Issue: Volume 6:Issue 12(2016) Page Start: 1227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MiR-187-3p inhibits the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by targeting S100A4. Issue 2 (28th October 2016) Authors: Dou, Changwei; Liu, Zhikui; Xu, Meng; Jia, Yuli; Wang, Yufeng; Li, Qing; Yang, Wei; Zheng, Xin; Tu, Kangsheng; Liu, Qingguang Journal: Cancer letters Issue: Volume 381:Issue 2(2016) Page Start: 380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P300 Acetyltransferase Is a Cytoplasm‐to‐Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in Transforming Growth Factor β–Stimulated Hepatic Stellate Cells. Issue 4 (23rd May 2019) Authors: Wang, Yuanguo; Tu, Kangsheng; Liu, Donglian; Guo, Luyang; Chen, Yunru; Li, Qing; Maiers, Jessica L.; Liu, Zhikui; Shah, Vijay H.; Dou, Changwei; Tschumperlin, Daniel; Voneschen, Luke; Yang, Rendong; Kang, Ningling Journal: Hepatology Issue: Volume 70:Issue 4(2019) Page Start: 1409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1. Issue 1 (28th May 2016) Authors: Li, Qing; Liu, Zhikui; Xu, Meng; Xue, Yumo; Yao, Bowen; Dou, Changwei; Jia, Yuli; Wang, Yufeng; Tu, Kangsheng; Zheng, Xin; Yao, Yingmin Journal: Cancer letters Issue: Volume 375:Issue 1(2016) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Update in clinical management for gallbladder neuroendocrine carcinoma. Issue 14 (9th April 2021) Authors: Chu, Hongwu; Shi, Ying; Liu, Junwei; Huang, Dongsheng; Zhang, Jungang; Dou, Changwei Other Names: Nair. Sreenath section editor. Journal: Medicine Issue: Volume 100:Issue 14(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗